Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial

Mikkael A. Sekeres, Pau Montesinos, Jan Novak, Jianxiang Wang, Deepa Jeyakumar, Benjamin Tomlinson, Jiri Mayer, Erin Jou, Tadeusz Robak, David C. Taussig, Hervé Dombret, Akil Merchant, Naveed Shaik, Thomas O’Brien, Whijae Roh, Xueli Liu, Wendy Ma, Christine G. DiRienzo, Geoffrey Chan, Jorge E. Cortes

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences